683 Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601K Sell
63,060
-497,543
-89% -$4.25M 0.03% 127
2026
Q1
$3.08M Buy
560,603
+56,635
+11% +$627K 0.16% 91
2025
Q4
$13.3M Buy
503,968
+116,468
+30% +$2.25M 0.58% 39
2025
Q3
$7.39M Buy
387,500
+333,750
+621% +$5.2M 0.39% 57
2025
Q2
$1.04M Sell
53,750
-417
-0.8% -$8.08K 0.07% 112
2025
Q1
$774K Hold
54,167
– – 0.05% 123
2024
Q4
$1.34M Buy
54,167
+2,084
+4% +$58.2K 0.08% 102
2024
Q3
$1.58M Sell
52,083
-1,500
-3% -$58.7K 0.12% 94
2024
Q2
$2.63M Sell
53,583
-8,917
-14% -$688K 0.2% 81
2024
Q1
$4.72M Buy
+62,500
New +$6.31M 0.35% 58

Other funds holding GUTS

683 Capital Management's GUTS Position: Q2 2026 in Review

683 Capital Management reduced its Fractyl Health (GUTS) stake by 89% in Q2 2026, selling an estimated $4.25M and leaving 63,060 shares worth $601K. The position accounts for 0.03% of the portfolio, ranked #127.

683 Capital Management first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $13.3M in Q4 2025. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • 683 Capital Management held 63,060 shares of Fractyl Health worth $601K as of Q2 2026.
  • 683 Capital Management sold 497,543 Fractyl Health shares in Q2 2026, an estimated $4.25M.
  • Fractyl Health made up 0.03% of 683 Capital Management's portfolio in Q2 2026, its #127 holding.
  • 683 Capital Management first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • 683 Capital Management's Fractyl Health position peaked at $13.3M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.